iwNHL 2015: Selinexor, selective inhibitor of nuclear export, for non-Hodgkin lymphoma - 101793

Spotlight
Video

iwNHL 2015: Selinexor, selective inhibitor of nuclear export, for non-Hodgkin lymphoma

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Kuruvilla, MD, of Princess Margaret Cancer Centre, Toronto, Canada, discusses the early clinical activity of selinexor, an oral selective inhibitor of nuclear export (SINE) exportin 1 (XPO1) antagonist, for the treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma and Richter's transformation.

—————

The Video Journal of Hematological Oncology (VJHemOnc) is an independent, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve understanding and awareness of hematological malignancies.

Website: http://www.vjhemonc.com/...
Twitter: https://twitter.com/VJHemOn...
Facebook: https://www.facebook.com/vj...
LinkedIn: https://www.linkedin.com/co...
Shared By : VJHemOnc
Posted on : 11/22/15
Added : 3 years ago